1.
A Piga, R Galanello, GL Forni, MD Cappellini, R Origa, A Zappu, G Donato, E Bordone, A Lavagetto, L Zanaboni, R Sechaud, N Hewson, JM Ford, H Opitz, D Alberti. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. haematol [Internet]. 2006Jul.1 [cited 2024Apr.16];91(7):873-80. Available from: https://haematologica.org/article/view/4060